Press Releases

Feb 21, 2017

PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial

Feb 13, 2017

PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity

Feb 8, 2017

PharmaCyte Biotech Releases Shareholder Call and Complete Q&A Playback Information

Feb 2, 2017

PharmaCyte Biotech Provides Update for February 7th Shareholder Call

Jan 30, 2017

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

Jan 18, 2017

PharmaCyte Biotech to Hold Shareholder Call

Jan 10, 2017

PharmaCyte Biotech Discusses Upcoming Clinical Trial with Principal Investigator Dr. Manuel Hidalgo

Jan 4, 2017

PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

Dec 27, 2016

PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

Dec 15, 2016

PharmaCyte Biotech Submits Pre-IND Meeting Package to FDA

« Previous
1
2
3
4
5
6
7
8
9
10
...18
Next »